Generic Name: mesalamine
More frequent side effects include: constipation, dyspepsia, skin rash, and vomiting.  See below for a comprehensive list of adverse effects.
Applies to mesalamine: oral capsule delayed release, oral capsule extended release, oral tablet, oral tablet delayed release, oral tablet enteric coated
Other dosage forms:
In addition to its needed effects, some unwanted effects may be caused by mesalamine (the active ingredient contained in Lialda). In the event that any of these side effects do occur, they may require medical attention.
You should check with your doctor immediately if any of these side effects occur when taking mesalamine:
Some of the side effects that can occur with mesalamine may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:


Applies to mesalamine: compounding powder, oral capsule extended release, oral delayed release capsule, oral delayed release tablet, rectal enema, rectal kit, rectal suppository
The most common adverse events were headache, eructation, and aggravation of ulcerative colitis.[Ref]
Very common (10% or more): Eructation (up to 16%), ulcerative colitis aggravated (up to 15%) Common (1% to 10%): Abdominal pain/cramps/discomfort, diarrhea, flatulence, nausea, gastroenteritis, gastrointestinal hemorrhage, rectal disorder, stool abnormalities (color or texture change), urinary frequency, dyspepsia, vomiting, bloating, rectal distension, pain on insertion of tip (enema formulation), hemorrhoids, rectal pain, colitis, constipation, abdominal distension Uncommon (0.1% to 1%): Acute pancreatitis, melena (bloody diarrhea), rectal pain/soreness/burning, pancolitis, neonate diarrhea, anal discomfort, defecation urgency, colitis ulcer (proctitis ulcer), glossitis, rectal polyp, pancreatitis, application site irritation (rectal foam formulation), painful rectal tenesmus, rectal urgencyRare (less than 0.1%): Increased amylaseFrequency not reported: Duodenal ulcer, dysphagia, esophageal ulcer, fecal incontinence, GI bleeding, mouth ulcer, oral candidiasis, rectal bleeding, rectal polyp, mild indigestion and cramping, bloody diarrhea, stomatitis, abdominal enlargement, lipase increase Postmarketing reports: Frequent bowel movements, mucus stools, painful defecation, proctalgia, rectal discharge, stomach discomfort, gastritis, dry mouth, oral ulcers, perforated peptic ulcer, amylase increased[Ref]
Very common (10% or more): Headache (up to 24%)Common (1% to 10%): Dizziness Uncommon (0.1% to 1%): Paresthesia, peripheral neuropathy, somnolence, tremor, Very rare (less than 0.01%): VertigoFrequency not reported: Neuropathy, mild disorientationPostmarketing reports: Guillain-Barre syndrome, hypertonia, transverse myelitis, hyperesthesia, taste perversion, tinnitus[Ref]
Very common (10% or more): Pain (up to 14%)Common (1% to 10%): Asthenia, fatigue, pyrexia, infectionUncommon (0.1% to 1%): Ear pain, peripheral edema Rare (less than 0.1%): Drug feverFrequency not reported: Malaise, mesalamine-induced acute intolerance syndrome, plugged ears, adenovirus infection, aching, decreased body mass index,Postmarketing reports: Medication residue, elevated alkaline phosphatase, elevated GGT, elevated LDH, ear congestion[Ref]
Very common (10% or more): Nasopharyngitis (up to 15%)Common (1% to 10%): Upper respiratory tract infection, influenza like symptoms, rhinitis, cold/sore throatUncommon (0.1% to 1%): Allergic and fibrotic lung reactions, dyspnea, cough, bronchospasm, pleural effusion, alveolitis, pulmonary eosinophilia, lung infiltration, pneumonitis, pharyngolaryngeal painVery rare (less than 0.01%): Eosinophilic pneumoniaFrequency not reported: Hypersensitivity pneumonitis (including interstitial pneumonitis, allergic alveolitis, eosinophilic pneumonitis, stuffy head, interstitial pulmonary fibrosis, bronchiolitis obliterans, sinusitisPostmarketing reports: Fibrosing alveolitis, asthma exacerbation, pleuritis, bronchitis[Ref]
Common (1% to 10%): Hypertension, vasodilation, Uncommon (0.1% to 1%): Pericarditis, myocarditis, pericardial effusion, tachycardia, hypotensionFrequency not reported: Chest pain, T-wave abnormalities, Kawasaki-like syndrome[Ref]
Common (1% to 10%): Rash, alopecia, urticaria, pruritus, acneUncommon (0.1% to 1%): Lupus erythematosus syndrome, allergic exanthema, increased sweating, angioedema, Stevens-Johnson syndrome, face edemaVery rare (less than 0.01%): Reversible alopecia, bullous skin reactions including erythema multiforme Frequency not reported: Dry skin, eczema, erythema nodosum, nail disorder, photosensitivity, lichen planus, ecchymosisPostmarketing reports: Prurigo, erythema, psoriasis, pyoderma gangrenosum[Ref]
Common (1% to 10%): Back pain, arthralgia, leg/joint pain Uncommon (0.1% to 1%): Myalgia, chills, myositis, arthritisFrequency not reported: Leg cramps, lower back discomfort, muscle cramps, neck painPostmarketing reports: Joint disorder, rheumatoid arthritis[Ref]
Common (1% to 10%): Hepatic function abnormal, increased alanine aminotransferaseUncommon (0.1% to 1%): Hepatitis, increased liver enzymes (transaminase activity), intrahepatic cholestasis, increased bilirubinVery rare (less than 0.01%): Hepatotoxicity (including cirrhosis, hepatic failure), changes in liver function parametersFrequency not reported: GGTP increase, SGOT increase, SGPT increase, sclerosing cholangitis, increased alkaline phosphatasePostmarketing reports: Jaundice, cholestatic jaundice, liver necrosis, cholecystitis[Ref]
Common (1% to 10%): AnorexiaFrequency not reported: Thirst, edemaPostmarketing reports: Increased appetite, gout[Ref]
Common (1% to 10%): Vision abnormalities Uncommon (0.1% to 1%): ConjunctivitisPostmarketing reports: Blurred vision, eye pain[Ref]
Uncommon (0.1% to 1%): Acute or chronic interstitial nephritis, renal insufficiency, renal failure, nephrotoxicityVery rare (less than 0.01%): Nephrotic syndrome, urine discolorationFrequency not reported: Creatinine clearance decreasedPostmarketing reports: Minimal change nephropathy, elevated serum creatinine and BUN[Ref]
Uncommon (0.1% to 1%): Thrombocytopenia, aplastic anemia, hemolytic anemia, agranulocytosis, leukopenia, neutropenia, pancytopenia, platelet count decreasedVery rare (less than 0.01%): Eosinophilia (as part of an allergic reaction), anemia, bone marrow depressionFrequency not reported: ThrombocythemiaPostmarketing reports: Granulocytopenia, lymphadenopathy[Ref]
Uncommon (0.1% to 1%): Allergic reaction, anaphylactic reaction, drug reaction with eosinophilia and systemic symptoms (DRESS)Frequency not reported: Anaphylactic shock, angioedema[Ref]
Uncommon (0.1% to 1%): Oligospermia (reversible), UTI/urinary burningFrequency not reported: Albuminuria, amenorrhea, breast pain, hematuria, hypomenorrhea, menorrhagia, metrorrhagia, urinary frequencyPostmarketing reports: Dysuria, urinary urgency, epididymitis[Ref]
Uncommon (0.1% to 1%): InsomniaFrequency not reported: Depression, anxiety, decreased libidoPostmarketing reports: Nervousness, confusion, emotional lability, confusion[Ref]
1. "Product Information. Lialda (mesalamine (5-aminosalicylic acid))." Shire US Inc, Florence, KY. 
2. "Product Information. Rowasa product information (mesalamine)." Solvay Pharmaceuticals Inc, Marietta, GA. 
3. "Product Information. Pentasa Product Information (mesalamine)." Hoechst Marion-Roussel Inc, Kansas City, MO. 
4. "Product Information. Asacol product information (mesalamine)." Procter and Gamble Pharmaceuticals, Cincinnati, OH. 
5. Cerner Multum,  Inc. "Australian Product Information." O 0
6. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0
7. "Product Information. Delzicol (mesalamine (5-aminosalicylic acid))." Warner Chilcott Laboratories, Rockaway, NJ. 
8. "Product Information. Canasa (mesalamine (5-aminosalicylic acid))." Axcan Scandipharm Inc, Birmingham, AL. 
9. "Product Information. Apriso (mesalamine (5-aminosalicylic acid))." Salix Pharmaceuticals, Raleigh, NC. 
Not all side effects for Lialda may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.
rectal enema, rectal suppository

Abdominal or stomach pain (severe)
bloody diarrhea
rectal bleeding


Abdominal or stomach cramps (severe)
blurred vision
dizziness
fever
full or bloated feeling
headache (severe)
nervousness
pounding in the ears
pressure in the stomach
skin rash and itching
slow or fast heartbeat
swelling of the abdominal or stomach area
unusual tiredness or weakness


Anxiety
back pain (severe)
blue or pale skin
chest pain, possibly moving to the left arm, neck, or shoulder
chills
nausea or vomiting
yellow eyes or skin


Abdominal or stomach cramps or pain (mild)
diarrhea (mild)
headache (mild)
runny or stuffy nose
sneezing


Acid or sour stomach
acne
back or joint pain
belching
difficulty with moving
excess air or gas in the stomach or intestines
hair loss or thinning of the hair
heartburn
indigestion
loss of appetite
muscle pain or stiffness
passing gas
stomach discomfort or upset

